Product Description
Myeloma is a form of cancer that rises from white blood cells called B lymphocytes. The disease usually causes malignant cells to grow within bone marrow. These cells interfere with marrow function as well as the immune system. Risk for myeloma has been linked to old age, being overweight, and environmental factors such as radiation exposure. Myeloma draws upon the most current medical research to explain the biology of this form of cancer, how it is diagnosed, and how it is treated.

SIMILAR PRODUCTS

	Multiple Myeloma: The Plain English Handbook for Patients and Care Givers by Robert, J Heller (Author) A concise and helpful overview of the disease, including therapies, medications, problems, and lifestyle changes. Many helpful hints in an easy to understand format which avoids a lot of hard to understand terminology in favor of a more light-hearted approach. Includes reproducible forms and many references to other sources.
	100 Questions and Answers About Myeloma (100 Questions & Answers about . . .) by Asad Bashey (Author), Rafat Abonour (Author) Whether you are a newly diagnosed myeloma patient, a survivor, or a friend or relative of either, this book offers help. The only text to provide the doctor s and patient s views, 100 Questions & Answers About Myeloma gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. Written by a hematologist-oncologist specializing in myeloma treatment, and featuring insider advice from an actual patient,...
	Multiple Myelomas, An Issue of Hematology / Oncology Clinics (The Clinics: Internal Medicine) by Kenneth C. Anderson MD (Author) Although treatable with conventional and high dose therapies, multiple myeloma (MM) remains incurable. However, recent advances in oncogenomics, coupled with increased understanding of the role of the bone marrow (BM) microenvironment in MM pathogenesis, has provided the basis for a new treatment paradigm targeting the tumor cell in the BM milieu to overcome conventional drug resistance and improve patient outcome. This text will first describe advances in molecular pathogenesis of MM due to...
	Myeloma Therapy:: Pursuing the Plasma Cell (Contemporary Hematology) by Sagar Lonial (Editor) Therapeutic options for patients with myeloma have radically changed over the past ten years. Beginning with the advances in therapy resulting from the use of high dose therapy and autologous bone marrow or stem cell transplant, we have more than doubled the median survival for patients as a whole, and have now a wealth of different biology based treatment approaches for our patients in all disease stages. The purpose of this book is to update the various treatment options for patients with...
	Multiple Myeloma: Translational and Emerging Therapies (Translational Medicine) by Kenneth C. Anderson (Author), Irene M. Ghobrial (Editor) Multiple myeloma is the second most prevalent hematological malignancy, with over 55,000 new cases diagnosed each year. This exciting new text, edited by lauded authorities on the topic, stands as the only available reference to assemble, review, and synthesizes the latest studies on translational therapies and clearly explains the impact of molecular pathogenesis, biology, and prognostic factors on the diagnosis, prognosis, and individualization of treatment and the development of novel...